Asprosin in Behect Patients
NCT07803198 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 44
Last updated 2026-09-03
Summary
This study aims to investigate serum Asprosin concentrations in patients with BD and their relationship with disease activity and major clinical manifestations.
Conditions
- Behcet Disease
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Marwa Ahmed Abdel- aziz Galal, MD · Assiut University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-09-01
- Primary Completion
- 2027-09-30
- Completion
- 2027-10-30
More Related Trials
-
Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Risk of COVID_19
NCT05398731 ·Status: UNKNOWN
-
Aspirin Responsiveness in Women at Risk for Cardiac Events
NCT00818337 ·Status: COMPLETED ·Phase: PHASE4
-
Tolerability of Asasantin in Healthy Female and Male Subjects
NCT02269228 ·Status: COMPLETED ·Phase: PHASE1
-
Intermittent or Continuous Acetylsalicylic Acid and Gene Expression in the Nasal Tissue of Current Smokers
NCT02123849 ·Status: COMPLETED ·Phase: PHASE2
-
Metabolomic and Inflammatory Effects of Oral Aspirin (ASA) in Subjects at Risk for Melanoma
NCT04062032 ·Status: COMPLETED ·Phase: PHASE2
-
ASPREE Cancer Endpoints Study
NCT01968798 ·Status: UNKNOWN ·Phase: PHASE4
-
Appropriateness of Aspirin Use in Medical Outpatients
NCT03387384 ·Status: UNKNOWN
-
ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension
NCT05056896 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Survival and 30-days Hospital Outcome in COVID-19 Patients in Upper Egypt
NCT04488588 ·Status: COMPLETED
-
First Approach for Aspirin Misuse Objective Screening
NCT02997436 ·Status: COMPLETED ·Phase: NA
-
Adherence to Universal Aspirin Compared to Screening Indicated Aspirin for Prevention of Preeclampsia
NCT04797949 ·Status: WITHDRAWN ·Phase: PHASE4
-
Comparative Effects of Aspirin, Metformin and SGLT2 Inhibitors on Liver Enzymes, Lipid Profile, and FibroScan Findings in Non-Alcoholic Fatty Liver Disease
NCT07338331 ·Status: COMPLETED ·Phase: NA
-
Aspirin Responsiveness in Women With Coronary Artery Disease
NCT01406990 ·Status: COMPLETED
-
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Olpasiran in Chinese Participants With Elevated Serum Lipoprotein(a)
NCT04987320 ·Status: COMPLETED ·Phase: PHASE1
-
Risk of Uncomplicated Peptic Ulcer in the General Population
NCT01888588 ·Status: COMPLETED
-
Dupilumab for Aspirin-exacerbated Respiratory Disease
NCT03595488 ·Status: COMPLETED ·Phase: PHASE2
-
Addition of Aspirin to Standard of Care in Oral Cancer
NCT05865548 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Hs-CRP as Clinical Marker of Inflammatory Atherogenic Dyslipidemia
NCT00169871 ·Status: COMPLETED
-
Aspirin Dose and Atherosclerosis in Patients With Metabolic Syndrome
NCT00272311 ·Status: COMPLETED ·Phase: PHASE4
-
Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current Smokers
NCT02348203 ·Status: COMPLETED ·Phase: PHASE2
-
ASA Patterns for Prevention of Preeclampsia in SLE Pregnancies
NCT03749044 ·Status: COMPLETED ·Phase: NA
-
The Study on Profile and Genetic Factors of Aspirin Resistance (ProGEAR Study)
NCT00250380 ·Status: COMPLETED
-
Effect of Aspirin on Abacavir-induced Platelet Reactivity in HIV-infected Patients
NCT03316534 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Interaction Between Aspirin and Nexium
NCT01199328 ·Status: COMPLETED ·Phase: PHASE1
-
Outcomes of Rivaroxaban and Aspirin in PAD After Endovascular Revascularization
NCT05308030 ·Status: UNKNOWN ·Phase: EARLY_PHASE1